UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 236

Sortiert nach

An update on GM-CSF and its potential role in melanoma management

Melanoma management, 2020-09, Vol.7 (3), p.MMT49-MMT49

Dillman, Robert O

2020

Link zum Volltext

Verfügbarkeit prüfen

Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial

Journal of translational medicine, 2020-04, Vol.18 (1), p.176-176, Article 176

2020

Link zum Volltext

Verfügbarkeit prüfen

Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines

Human vaccines & immunotherapeutics, 2023-12, Vol.19 (1), p.2198467-2198467

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2006-10, Vol.24 (29), p.4721-4730

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

Journal of experimental & clinical cancer research, 2022-12, Vol.41 (1), p.344-9

2022

Link zum Volltext

Verfügbarkeit prüfen

An update on the relevance of vaccine research for the treatment of metastatic melanoma

Melanoma management, 2017-12, Vol.4 (4), p.203-215

Dillman, Robert O

2017

Link zum Volltext

Verfügbarkeit prüfen

Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine

Human vaccines & immunotherapeutics, 2020-04, Vol.16 (4), p.742-755

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

Journal for immunotherapy of cancer, 2018-03, Vol.6 (1), p.19-19, Article 19

2018

Link zum Volltext

Verfügbarkeit prüfen

A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (6), p.2100189-2100189

2022

Link zum Volltext

Verfügbarkeit prüfen

Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma

Melanoma management, 2019-06, Vol.6 (2), p.MMT20-MMT20

2019

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibodies in cancer therapy: 25 years of progress

Journal of clinical oncology, 2008-04, Vol.26 (11), p.1774-1777

2008

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival Benefit From Postoperative Radiation Therapy for Organ-Confined, Margin-Positive Prostate Cancer

International journal of radiation oncology, biology, physics, 2011-03, Vol.79 (3), p.719-723

2011

Link zum Volltext

Verfügbarkeit prüfen

Cancer vaccines: can they improve survival?

Cancer biotherapy & radiopharmaceuticals, 2015-05, Vol.30 (4), p.147

Dillman, Robert O

2015

Link zum Volltext

Verfügbarkeit prüfen

Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma

Journal of immunotherapy (1997), 2004-09, Vol.27 (5), p.398

2004

Link zum Volltext

Verfügbarkeit prüfen

1411 Feasibility, safety, and efficacy of personal vaccines consisting of autologous dendritic cells loaded ex vivo with autologous tumor antigens from self-renewing cancer cells

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1569-A1569

2023

Link zum Volltext

Verfügbarkeit prüfen

Surgical Resection and Long-Term Survival for Octogenarians Who Undergo Surgery for Non–Small-Cell Lung Cancer

Clinical lung cancer, 2009-03, Vol.10 (2), p.130-134

2009

Link zum Volltext

Verfügbarkeit prüfen

Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma

Journal of clinical oncology, 2002-08, Vol.20 (16), p.3545-3557

DILLMAN, Robert O

2002

Link zum Volltext

Verfügbarkeit prüfen

Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?

Expert opinion on biological therapy, 2013-05, Vol.13 (5), p.643-656

2013

Link zum Volltext

Verfügbarkeit prüfen

Seizures as treatment-emergent adverse events during glioblastoma clinical trials

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e14018-e14018

Dillman, Robert O.

2022

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

The New England journal of medicine, 1990-10, Vol.323 (14), p.940-945

1990

Link zum Volltext

Verfügbarkeit prüfen

Steadily Improving Survival in Lung Cancer

Clinical lung cancer, 2014-09, Vol.15 (5), p.331-337

2014

Link zum Volltext

Verfügbarkeit prüfen

Pentostatin (Nipent®) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia

Expert review of anticancer therapy, 2004-02, Vol.4 (1), p.27-36

Dillman, Robert O

2004

Link zum Volltext

Verfügbarkeit prüfen

Defining the critical hurdles in cancer immunotherapy

Journal of translational medicine, 2011-12, Vol.9 (1), p.214-214, Article 214

2011

Link zum Volltext

Verfügbarkeit prüfen

Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance

Cancer, 2009-05, Vol.115 (9), p.1840-1848

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 236

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(186)

Publikationsform

Artikel
(214)
Buchkapitel
(11)
Reviews
(5)
Bücher
(4)
Berichte
(2)

Sprache

Englisch
(236)
Japanisch
(14)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(148)
Science & Technology
(148)
Humans
(140)
Oncology
(120)
Female
(70)
Biological And Medical Sciences
(67)
Medical Sciences
(66)
Middle Aged
(64)
Medicine, Research & Experimental
(60)
Research & Experimental Medicine
(60)
Male
(59)
Immunotherapy
(50)
Pharmacology. Drug Treatments
(46)
Antineoplastic Agents
(45)
Adult
(43)
Aged
(41)
Radiology, Nuclear Medicine & Medical Imaging
(37)
Pharmacology & Pharmacy
(35)
Melanoma
(31)
Dendritic Cells
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An update on GM-CSF and its potential role in melanoma management

Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial

Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines

Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

An update on the relevance of vaccine research for the treatment of metastatic melanoma

Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine

Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses

Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma

Monoclonal antibodies in cancer therapy: 25 years of progress

Overall Survival Benefit From Postoperative Radiation Therapy for Organ-Confined, Margin-Positive Prostate Cancer

Cancer vaccines: can they improve survival?

Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma

1411 Feasibility, safety, and efficacy of personal vaccines consisting of autologous dendritic cells loaded ex vivo with autologous tumor antigens from self-renewing cancer cells

Surgical Resection and Long-Term Survival for Octogenarians Who Undergo Surgery for Non–Small-Cell Lung Cancer

Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma

Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?

Seizures as treatment-emergent adverse events during glioblastoma clinical trials

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

Steadily Improving Survival in Lung Cancer

Pentostatin (Nipent®) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia

Defining the critical hurdles in cancer immunotherapy

Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance

Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy

Suchergebnisse filtern